Detection of Leishmania parasites species isolated from patients suffering from Kala-azar using one-step PCR

Introduction:Visceral leishmaniasis (Kala-azar) is a major parasitic disorder caused by species of Leishmania genus, namely L. donovani and L. infantum. Epidemiologic evidence indicates that visceral leishmaniasis is common in certain regions of Jahrom town in the province of Fars, Iran. The present...

Full description

Bibliographic Details
Published in:	فصلنامه دانشگاه علوم پزشکی جهرم
Main Authors:	Ahmad Golkar, Seyed Ali Hashemi, Mohammad Hosein Motazedian, Mahdi Fakhar
Format:	Article
Language:	Persian
Published:	Jahrom University of Medical Sciences 2011-08-01
Subjects:	Visceral Leishmaniasis Kala-azar L. Infantum Polymerase Chain Reaction Bone Marrow
Online Access:	http://jums.hbi.ir/library/upload/article/af_33952293534574583624232329224936865922224.Fakhar.pdf

Similar Items

A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery
by: Md. Mehedi Hasan, et al.
Published: (2023-12-01)

Post-kala-azar dermal leishmaniasis associated with AIDS
by: Achiléa Bittencourt, et al.

Recurrent kala-azar: report of two cured cases after total splenectomy
by: Luis Gustavo Cavalcante Reinaldo, et al.

Kala-azar in Maraveh Tapeh county, Golestan Provice, Iran: Seven case reports
by: M Qorbani, et al.
Published: (2017-05-01)

Macular form of post-kala-azar dermal leishmaniasis: Clinical features, diagnosis, and significance in the Kala-Azar Elimination Programme
by: V. Ramesh, et al.
Published: (2025-06-01)

Upendranath Brahmachari: Revisiting a Forgotten Bengali Scientist behind Cure of Kala-azar
by: Rupak Chatterjee, et al.
Published: (2025-03-01)

Nutritional status and vitamin A and zinc levels in patients with kala-azar in Piauí, Brazil
by: Mísia Joyner de Sousa Dias Monteiro, et al.
Published: (2021-09-01)

Role of IL-17 gene polymorphism in Indian kala-azar
by: R Khatonier, et al.
Published: (2020-01-01)

Blood parasite load by qPCR as therapeutic monitoring in visceral leishmaniasis patients in Brazil: a case series study
by: Samuel Ricarte de Aquino, et al.
Published: (2023-03-01)

Addressing research questions in visceral leishmaniasis and post-kala-azar dermal leishmaniasis: Potential of reusing data from the Infectious Diseases Data Observatory platform
by: Prabin Dahal, et al.
Published: (2025-06-01)

Visceral Leishmaniasis during Italian Renaissance, 1522–1562
by: Andreas G. Nerlich, et al.
Published: (2012-01-01)

Community-based active case detection of hidden visceral leishmaniasis and post-kala-azar dermal leishmaniasis cases to support the elimination of visceral leishmaniasis in Bihar, India
by: Kuldeep Singh Deepak, et al.
Published: (2025-04-01)

DNA-based detection of Leishmania and Crithidia species isolated from humans in cutaneous and post-kala-azar dermal leishmaniasis from Shiraz and Kharameh, southern Iran
by: Mohsen Kalantari, et al.
Published: (2020-01-01)

Characterization of Leishmania Parasites Isolated From Kala- azar Patients in Kohgiloyeh and Boyerahmad, Using Semi-Nested PCR
by: B Sarkari, et al.
Published: (2006-04-01)

Can cutaneous leishmaniasis provoke a resurgence of kala-azar in the Indian subcontinent?
by: Narayan Raj Bhattarai, et al.
Published: (2025-02-01)

Visceral leishmaniasis: An immunological viewpoint on asymptomatic infections and post kala azar dermal leishmaniasis
by: Neeraj Tiwari, et al.
Published: (2018-01-01)

The spleen is the graveyard of CD4+ cells in patients with immunological failure of visceral leishmaniasis and AIDS
by: Luis Gustavo Cavalcante Reinaldo, et al.
Published: (2024-03-01)

Kala-azar in Qadisiah : A clinicoepidemiological descriptive study
by: Mohammed mojar Al-Shamsi, et al.
Published: (2008-07-01)

Comparison of optical microscopy and quantitative polymerase chain reaction for estimating parasitaemia in patients with kala-azar and modelling infectiousness to the vector Lutzomyia longipalpis
by: Jailthon C Silva, et al.
Published: (2016-08-01)

Plasma levels of tumor necrosis factor-alpha in patients with visceral leishmaniasis (Kala-Azar). Association with activity of the disease and clinical remisson following antimonial therapy Níveis plasmáticos do fator de necrose tumoral-alfa (TNF-alfa) em pacientes com leishmaniose visceral (Calazar). Associação com atividade da doença e remissão clínica com terapia antimonial
by: Reinaldo Salomão, et al.
Published: (1996-04-01)

Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination
by: Awnish Kumar, et al.
Published: (2023-08-01)

Mapping the immune landscape in South Asian post kala-azar dermal leishmaniasis
by: Madhurima Roy, et al.
Published: (2025-06-01)

A clinico-epidemiological study, assessing possible predictors of mortality and health-related quality of life for people living with visceral leishmaniasis – human immune virus (VL-HIV) co-infection in a high burden kala-azar endemic state of India: a descriptive cross-sectional study
by: Niyamat Ali Siddiqui, et al.
Published: (2025-07-01)

Reworking the treatment of Indian Post kala-azar dermal leishmaniasis: A two-step therapy
by: Sushruta Kathuria, et al.
Published: (2025-04-01)

BLIMP-1 Mediated Downregulation of TAK1 and p53 Molecules Is Crucial in the Pathogenesis of Kala-Azar
by: Gundappa Saha, et al.
Published: (2020-10-01)

Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era
by: Sushmita Ghosh, et al.
Published: (2024-06-01)

Leishmaniose visceral americana (calazar) em crianças hospitalizadas de área endêmica American visceral leishmaniasis (kala-azar) in hospitalized children from an endemic area
by: Luís C. Rey, et al.
Published: (2005-02-01)

Nationwide cross-sectional surveillance of Leishmania donovani in phlebotomine sand flies and its impact on national kala-azar elimination in India
by: Harish Kumar Shah, et al.
Published: (2024-11-01)

Optimum Conditions Of 5-Nucleotidase Activity In Sera Of KalaAzaric Patients.
by: Eaman A.S. AL-Rubaee
Published: (2006-10-01)

Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report
by: José Angelo Lauletta Lindoso, et al.

Kala-azar and the contestations of its nomenclature
by: Anidrita Saikia
Published: (2025-06-01)

Prediction of visceral leishmaniasis development in a highly exposed HIV cohort in Ethiopia based on Leishmania infection markers: results from the PreLeisH studyResearch in context
by: Johan van Griensven, et al.
Published: (2024-12-01)

Controlling kala azar in Assam
by: Anidrita Saikia
Published: (2025-06-01)

Validation of Kala-azar diagnostic tests in a pediatric teaching hospital in Baghdad.
by: Muhi K. Al-Janabi, et al.
Published: (2014-10-01)

Characterisation of the Leishmania donovani/L. infantum Hybrid Isolated from an Autochothonous Kala-Azar Patient: Preliminary Results of an In Vivo Model
by: Özgür Kurt, et al.
Published: (2021-06-01)

Clinical and Immunopathological Aspects of Cutaneous, Mucocutaneous, Visceral, and Post-kala-azar Leishmaniasis
by: Basim Saleem Ahmed Al Sulivany, et al.
Published: (2023-09-01)

Increased natural killer activity does not prevent progression of experimental Kala-azar
by: Alexandrina SARTORI, et al.
Published: (1999-07-01)

Effectiveness of an Intervention in Improving Knowledge and Practices about Kala-azar in a Tribal Population of Eastern India
by: Pritama Paul, et al.
Published: (2024-06-01)

The potential of Leishmania donovani Aurora kinase in the diagnosis of Indian and Brazilian visceral leishmaniasis patients
by: Anirban Bhattacharyya, et al.
Published: (2025-06-01)

Seroprevalence and risk factors for canine visceral leishmaniasis in the endemic area of Dias D'Ávila, State of Bahia, Brazil Soroprevalência e fatores de risco para leishmaniose visceral canina na área endêmica de Dias D'Ávila, Estado da Bahia, Brasil
by: Laura Cristina Pinho de Oliveira, et al.
Published: (2010-08-01)